Peter Arduini reports 748.337 deferred units at Bristol-Myers Squibb (BMY)

Rhea-AI Filing Summary

Peter J. Arduini, a director of Bristol-Myers Squibb Company (BMY), reported acquisition of 748.337 Deferred Share Units on 09/30/2025. Each Deferred Share Unit will convert into one share of common stock upon settlement; the units become settleable when the reporting person ceases to be a director or at a previously specified future date. After this transaction the filing shows the reporting person beneficially owns 64,620.164 shares (this total includes deferred compensation and reinvested dividends under the company’s 1987 Deferred Compensation Plan for Non-Employee Directors). The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Positive

• Acquisition of 748.337 Deferred Share Units shows alignment of director compensation with shareholder equity
• Total beneficial ownership of 64,620.164 shares (including plan holdings) indicates meaningful stake held by the director

Negative

• None.

Insights

Corporate Governance Analyst

Director received 748.337 deferred units that convert to shares on settlement.

The filing documents a routine director compensation event: 748.337 Deferred Share Units were acquired on 09/30/2025. These units convert 1:1 into common shares upon settlement, typically tied to exit or a pre-specified date, indicating deferred equity pay rather than open-market trading.

The report lists total beneficial ownership of 64,620.164 shares, which the company says includes amounts held under the 1987 Deferred Compensation Plan for Non-Employee Directors. This clarifies that a portion of the director’s stake reflects accrued, plan-based holdings.

Compliance & SEC Reporting Specialist

Form 4 discloses a compensatory equity grant and appears procedurally complete.

The transaction is coded as an acquisition of deferred share units (compensation), not a market purchase or sale. The Form 4 shows the reporting person filed individually and the signature was provided by an attorney-in-fact on 10/02/2025.

No amendments, option exercises, or cash prices are reported; the filing contains explanatory notes about conversion and plan inclusion but no additional material disclosures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Arduini Peter J

(Last) (First) (Middle)

BRISTOL-MYERS SQUIBB COMPANY

ROUTE 206 AND PROVINCE LINE ROAD

(Street)

PRINCETON NJ 08543

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	09/30/2025		A		748.337		(1)	(1)	Common Stock, $0.10 par value	748.337	$0	64,620.164(2)	D

Explanation of Responses:

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Remarks:

	/s/ Sophie M. Bail, attorney-in-fact for Peter J. Arduini	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BMY director Peter J. Arduini report on Form 4?

He reported acquisition of 748.337 Deferred Share Units on 09/30/2025, which convert into common stock upon settlement.

How many Bristol-Myers Squibb (BMY) shares does the reporting person beneficially own after the transaction?

The filing shows beneficial ownership of 64,620.164 shares, including deferred compensation and reinvested dividends under the 1987 Deferred Compensation Plan for Non-Employee Directors.

When do the Deferred Share Units become settleable?

The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

Was the Form 4 filed jointly or by one reporting person?

The Form was filed by one reporting person (individual filing).

Who signed the Form 4 and when?

The Form 4 was signed by Sophie M. Bail, attorney-in-fact for Peter J. Arduini on 10/02/2025.